Register for our free email digests:
Roche Holding AG
http://www.roche.com
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Roche Holding AG
Eiger's Lonafarnib Loses EU Fast-Track Review Status
Eiger attributes the change in status of the EU marketing authorization application for lonafarnib to the need for an inspection and the ongoing coronavirus pandemic.
Finance Watch: 2020 Cell And Gene Therapy Funding Already Bests 2019
Private Company Edition: The Alliance for Regenerative Medicine’s half-year report shows the sector raised $10.7bn in the first half of 2020 versus $9.8bn raised in all of 2019. Also, DCVC Bio closed a $350m fund, new incubator opportunities and VC mega-deals for Dyne and Atomwise.
Is Disruption Just A Young Pup’s Game?
Big pharma has faced many evolutions to the pharma playbook of old. New technologies such as wearables introduce behavioral change to patients, while e-commerce giants such as Amazon seek a piece of the Rx action. The health care industry has done a reasonable job of weathering the storm inflicted on its core business model over the years, but it has yet to be a true disruptor. As the world marches on is pharma’s choice to disrupt, or inevitably be disrupted for good?
Roche’s Etrolizumab Failure ‘Removes Big Pipeline Opportunity’
Roche’s etrolizumab missed primary endpoints in its Phase III study program evaluating it as maintenance therapy in moderately to severely active ulcerative colitis, a new therapeutic area for the firm.
Company Information
- Industry
- In Vitro Diagnostics
- Pharmaceuticals
- Other Names / Subsidiaries
-
- Adheron Therapeutics
- Anadys Pharmaceuticals, Inc.
- Ariosa Diagnostics
- Arius Research, Inc.
- Boehringer Mannheim
- CAPP Medical
- Chugai Pharmaceutical Co., Ltd.
- Dutalys GmbH
- Flatiron Health
- Foundation Medicine
- Genentech Inc.
- GeneWEAVE BioSciences, Inc.
- Genia Technologies, Inc.
- GlycArt Biotechnology
- Hoffmann-La Roche
- Ignyta, Inc. (RXDX) (Actagene Oncology, Inc
- NexDx, Inc.)
- Inception 5
- InterMune, Inc.
- IQuum, Inc.
- Jecure Therapeutics
- Kapa Biosystems, Inc.
- Marcadia Biotech, Inc.
- Medingo Ltd.
- Memory Pharmaceuticals Corporation
- mtm laboratories AG
- Piramed Pharma
- Santaris Pharma A/S
- Seragon Pharmaceuticals
- Signature Diagnostics AG
- Stratos Genomics
- Syntex Corporation
- Tanox, Inc.
- Tensha Therapeutics, Trophos SA
- Ventana Medical Systems, Inc.
- Viewics, Inc.